BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$74.78 USD
+0.78 (1.05%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $74.75 -0.03 (-0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for BioTechne Corp falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 168.11 | 285.44 | 263.10 | 139.59 | 229.30 |
Depreciation/Amortization & Depletion | 111.71 | 107.24 | 101.07 | 87.75 | 82.74 |
Net Change from Assets/Liabilities | -10.11 | -90.58 | -69.52 | 29.26 | -5.25 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 29.27 | -47.71 | 30.62 | 95.57 | -101.57 |
Net Cash From Operating Activities | 298.98 | 254.39 | 325.27 | 352.16 | 205.22 |
Property & Equipment | -62.88 | -38.24 | -44.91 | -44.30 | -51.74 |
Acquisition/ Disposition of Subsidiaries | -169.71 | -101.18 | 0.00 | -225.35 | 0.00 |
Investments | 29.55 | -126.22 | -51.94 | 26.14 | 78.84 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -203.03 | -265.65 | -96.85 | -243.52 | 27.10 |
Uses of Funds
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -19.11 | 10.25 | -83.80 | 21.91 | 20.87 |
Issuance (Repayment) of Debt | -256.00 | -525.66 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 225.00 | 619.66 | -85.50 | -15.50 | -148.50 |
Payment of Dividends & Other Distributions | -50.42 | -50.29 | -50.19 | -49.62 | -48.90 |
Other Financing Activities | -21.87 | -31.35 | -23.37 | -19.34 | -7.27 |
Net Cash from Financing Activities | -122.40 | 22.62 | -242.85 | -62.55 | -183.80 |
Effect of Exchange Rate Changes | -2.33 | -3.36 | -12.09 | 6.37 | -2.77 |
Net Change In Cash & Equivalents | -28.78 | 8.00 | -26.52 | 52.47 | 45.74 |
Cash at Beginning of Period | 180.57 | 172.57 | 199.09 | 146.63 | 100.89 |
Cash at End of Period | 151.79 | 180.57 | 172.57 | 199.09 | 146.63 |
Diluted Net EPS | 1.05 | 1.76 | 1.66 | 0.87 | 1.46 |
Fiscal Year End for BioTechne Corp falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 168.11 | 127.52 | 78.46 | 50.99 | 285.44 |
Depreciation/Amortization & Depletion | 111.71 | 83.65 | 56.34 | 28.54 | 107.24 |
Net Change from Assets/Liabilities | -10.11 | 0.13 | -1.20 | -19.98 | -90.58 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 29.27 | 12.18 | 8.90 | -0.17 | -47.71 |
Net Cash From Operating Activities | 298.98 | 223.49 | 142.50 | 59.38 | 254.39 |
Property & Equipment | -62.88 | -44.90 | -28.46 | -13.59 | -38.24 |
Acquisition/ Disposition of Subsidiaries | -169.71 | -169.71 | -169.71 | -166.43 | -101.18 |
Investments | 29.55 | 20.38 | 18.23 | 23.76 | -126.22 |
Other Investing Activities | 0.00 | 0.00 | 2.15 | 2.15 | 0.00 |
Net Cash from Investing Activities | -203.03 | -194.22 | -177.78 | -154.11 | -265.65 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -19.11 | -42.04 | -60.37 | 14.39 | 10.25 |
Issuance (Repayment) of Debt | -256.00 | -186.00 | -128.00 | -70.00 | -525.66 |
Increase (Decrease) Short-Term Debt | 225.00 | 225.00 | 225.00 | 160.00 | 619.66 |
Payment of Dividends & Other Distributions | -50.42 | -37.79 | -25.21 | -12.65 | -50.29 |
Other Financing Activities | -21.87 | -21.47 | -21.30 | -20.23 | -31.35 |
Net Cash from Financing Activities | -122.40 | -62.30 | -9.89 | 71.51 | 22.62 |
Effect of Exchange Rate Changes | -2.33 | -7.62 | -5.27 | -8.69 | -3.36 |
Net Change In Cash & Equivalents | -28.78 | -40.66 | -50.44 | -31.91 | 8.00 |
Cash at Beginning of Period | 180.57 | 180.57 | 180.57 | 180.57 | 172.57 |
Cash at End of Period | 151.79 | 139.92 | 130.13 | 148.66 | 180.57 |
Diluted Net EPS | 0.26 | 0.31 | 0.17 | 0.31 | 0.47 |